CD4 and cancer: TIMER2 suggested that the RBM10 expression was closely correlated with the infiltration levels of B cells in 14 types of cancer, CD8+ T cells in 22 types of cancer, CD4+ T cells in 18 types of cancer, neutrophils in 21 types of cancer, myeloid dendritic cells in 22 types of cancer, and macrophages in 19 types of cancer (Figure 5(a)).